TIDES Europe 2026

3-5 November 2026
Hynes RAI, Amsterdam, Netherlands

Accelerate Therapeutics to Market. Expedite R&D. Improve CMC Efficiency.

Join the leading oligonucleotides conference in Europe to access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies – from discovery to market.

Must-See Exhibitors at TIDES Europe 2026

Get to know the innovators shaping TIDES Europe 2026. These are the companies worth prioritizing on the show floor. Explore their sessions, visit their booths, and connect with the solutions driving the industry forward. Plan your path now so you can make every minute on-site count.

Explore Exhibitors & Book Meetings

Plan Your Event

Plan Your Days at TIDES Europe 2026!

Access new data & case studies from 115+ world-renowned speakers

Specialized Programming Tracks

Oligonucleotide Chemistry, Manufacturing & Controls: Comprehensive CMC, analytical, manufacturing, and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.
Oligonucleotide Discovery, Preclinical, and Clinical: Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.
Peptide Discovery to CMC: Explore the complete peptide development journey from synthesis and discovery through manufacturing and regulatory strategies, while improving targeting, delivery, and drug-like properties. Learn to overcome CMC challenges, understand regulatory expectations, and discover new technologies through case studies on the latest preclinical and clinical successes.

Pre-Conference Workshops

Workshop #1: CMC Decisions That Influence Cost of Goods (COGs) in Oligo Scale-up: Levers for Scientific and Commercial Impact
Workshop #2: Oligonucleotide CMC Across the Product Lifecycle: From Preclinical to Market
Workshop #3: Innovations and Challenges in Peptide Manufacturing and Purification

View Full Agenda

Keynote Sessions at TIDES Europe 2026

Shaping the Future of Oligonucleotide and Peptide Therapeutics

Featured Keynote Presentations:

Making Oligonucleotides a High-Volume Reality: Next-Gen Platforms and Strategy for Oligonucleotide Manufacturing

Nour Fahmi, PhD,
Director of Chemistry, Eli Lilly and Company

Tuesday, 3 November 2026 | 13:15 - 13:50

Next Generation GLP-1 Therapeutics

Explore the scientific and technological journey behind GLP-1–based therapies that have transformed metabolic disease treatment.

Jacob Challand Kofoed,
PhD, Scientific Director, Peptide Research 1, Novo Nordisk A/S

Tuesday, 3 November 2026 | 13:50 - 14:25

Retatrutide: From Breakthrough Science to Global Medicine — The CMC Story Behind a Novel GIP, GLP-1, and Glucagon Receptor Agonist

Gain an in-depth CMC perspective on the manufacturing innovation enabling global-scale supply of retatrutide.

Michael Kopach,
PhD, Associate Vice President, Synthetic Molecule Design and Development, Eli Lilly and Company

Tuesday, 3 November 2026 | 14:25 - 15:00

New Concepts in Nucleic Acid Chemistry for Site-specific Modification of RNA by Ribozymes and Chemically Modified Nucleic Acid Catalysts

Discover the architectures of recently discovered ribozymes and their strategic chemical modifications to enhance catalytic efficiency and stability.

Dr. Claudia Höbartner,
PhD, Professor of Organic Chemistry, University of Würzburg

Tuesday, 3 November 2026 | 15:50 - 16:25

Clinical Validation of ADAR RNA Editing and Translation to AI-driven Next-generation EONs

This presentation shows that the Axiomer ADAR-mediated RNA editing platform demonstrated favorable safety, dose-dependent target engagement, and strong preclinical-to-clinical translatability in a first-in-human healthy volunteer study, while AI-driven advances in next-generation oligonucleotide discovery have boosted potency and durability, underscoring the platform's promise for treating liver and CNS diseases.

Gerard Platenburg, PhD,
Chief Scientific Officer, ProQR Therapeutics

Tuesday, 3 November 2026 | 16:25 - 17:00

View Keynote Sessions

Outside the Sessions

Networking & Social Events at TIDES Europe 2026

Connect, Collaborate, and Recharge Throughout the Conference

TIDES Europe 2026 offers exceptional opportunities to build meaningful connections with peers, industry leaders, and innovators across oligonucleotide and peptide therapeutics.
Beyond the scientific programming, enjoy curated networking experiences and unique social events designed to foster collaboration in a relaxed atmosphere.

Day 1 – Tuesday, 3 November

Poster & Exhibit Hall Opening
Stroopwafel Bar in the Zen Den
Networking Break
Evening Reception in the Exhibit Hall

Day 2 – Wednesday, 4 November

Spotlight Presentations
TIDES Talks
TIDES Arcade in the Zen Den
Networking Breaks & Luncheon
Offsite Winter Market Reception

Day 3 – Thursday, 5 November

Spotlight Presentations
Event Masseuse in the Zen Den
Networking Breaks & Luncheon

View Agenda

Exhibit Hall: Where Solutions Meet Challenges

Discover the innovations driving biotech forward—all in one place.

Step into the heart of innovation at our expansive exhibit hall, where 100+ leading biotech companies, technology providers, and service partners showcase cutting-edge solutions. Explore the latest lab technologies, discover platforms that accelerate drug development, and connect directly with the experts who can solve your toughest challenges. Whether you’re sourcing new equipment, evaluating partnerships, or staying ahead of industry trends, the exhibit hall is your gateway to the tools and technologies shaping the future of biotech.

3-5 November 2026
Hynes RAI, Amsterdam, Netherlands

Accelerate Therapeutics to Market. Expedite R&D. Improve CMC Efficiency.

Must-See Exhibitors at TIDES Europe 2026

Plan Your Days at TIDES Europe 2026!

Access new data & case studies from 115+ world-renowned speakers

Specialized Programming Tracks

Pre-Conference Workshops

Keynote Sessions at TIDES Europe 2026

Shaping the Future of Oligonucleotide and Peptide Therapeutics

Featured Keynote Presentations:

Making Oligonucleotides a High-Volume Reality: Next-Gen Platforms and Strategy for Oligonucleotide Manufacturing

Next Generation GLP-1 Therapeutics

Retatrutide: From Breakthrough Science to Global Medicine — The CMC Story Behind a Novel GIP, GLP-1, and Glucagon Receptor Agonist

New Concepts in Nucleic Acid Chemistry for Site-specific Modification of RNA by Ribozymes and Chemically Modified Nucleic Acid Catalysts

Clinical Validation of ADAR RNA Editing and Translation to AI-driven Next-generation EONs

Outside the Sessions

Networking & Social Events at TIDES Europe 2026

Day 1 – Tuesday, 3 November

Day 2 – Wednesday, 4 November

Day 3 – Thursday, 5 November

Exhibit Hall: Where Solutions Meet Challenges

Discover the innovations driving biotech forward—all in one place.

View Full Agenda

Keynote Sessions

Outside The Sessions

Exhibit Hall

#TIDESEurope

3-5 November 2026Hynes RAI, Amsterdam, Netherlands

Accelerate Therapeutics to Market. Expedite R&D. Improve CMC Efficiency.

Must-See Exhibitors at TIDES Europe 2026

Making Oligonucleotides a High-Volume Reality: Next-Gen Platforms and Strategy for Oligonucleotide Manufacturing

Next Generation GLP-1 Therapeutics

Retatrutide: From Breakthrough Science to Global Medicine — The CMC Story Behind a Novel GIP, GLP-1, and Glucagon Receptor Agonist

New Concepts in Nucleic Acid Chemistry for Site-specific Modification of RNA by Ribozymes and Chemically Modified Nucleic Acid Catalysts

Clinical Validation of ADAR RNA Editing and Translation to AI-driven Next-generation EONs

View Full Agenda

Keynote Sessions

Outside The Sessions

Exhibit Hall

#TIDESEurope

3-5 November 2026
Hynes RAI, Amsterdam, Netherlands